Preclinical cardiac perforation reduction in leadless pacing: Anupdate to the Micra leadless pacemaker delivery system
Posted on August 7th, 2023
Class I Recall for 350,000 Medtronic Defibrillators: FDA
Posted on July 19th, 2023
Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation (HEAL)
Posted on July 14th, 2023
The objective of this multi-center study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo® envelope, TYRX™ envelope, or no envelope.
Sponsor: Aziyo Biologics
ClinicalTrials.gov ID: NCT04645173
The objective of this multi-center study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo® envelope, TYRX™ envelope, or no envelope.
Sponsor: Aziyo Biologics
ClinicalTrials.gov ID: NCT04645173